Bloomer Tech (AI) — Funding, Investors & Signals 2026

Bloomer Tech

Generating non-invasive digital biomarkers for women's health

Founded 2015

Cambridge, United States 8 employees Grant Total: $4.90M AI, Analytics +5

Bloomer Tech is a healthcare technology company founded in 2017 with the slogan "Generating non-invasive digital biomarkers for women's health." The company focuses on improving outcomes for women’s cardiovascular care by utilizing novel digital biomarkers and patented textile-based sensors. Their flagship product, the Bloomer Tech-Augmented Garment, is the world's first medical-grade device that resembles an everyday bra, pioneering a new age of personalized diagnostics. Bloomer's proprietary technology platform builds upon over 30 years of evidence-based research demonstrating sex and ethnicity-related differences in the cardiovascular system. This capability enables the generation of novel digital biomarkers that specifically address conditions that affect women disproportionately, differently, or uniquely. Their industry focus spans Analytics, Health Care, Information Technology, and Robotics, with the company headquartered in the United States. The latest investment of $1.90M in the form of a grant was secured on 08 November 2023 from the National Heart, Lung and Blood Institute, showcasing both financial support and validation from a reputable healthcare institution. Bloomer Tech's innovative approach to women's health and its ability to marry technology with healthcare has laid a strong foundation for potential growth and impact in the industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$1.90M	1	National Heart, Lung and Blood Institute	08 Nov 2023
Venture Round	Undisclosed	1	Catalytic Impact Foundation	01 Jan 2022
Non Equity Assistance	Undisclosed	1	MassChallenge	21 Oct 2020
Seed Round	$3.00M	4	Material Impact, John Abele +2	12 Mar 2020
Non Equity Assistance	Undisclosed	1	MIT delta v	09 Sep 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$1.90M

National Heart, Lung and Blood Institute

08 Nov 2023

Venture Round

Undisclosed

Catalytic Impact Foundation

01 Jan 2022

Non Equity Assistance

Undisclosed

MassChallenge

21 Oct 2020

Seed Round

$3.00M

Material Impact, John Abele +2

12 Mar 2020

Non Equity Assistance

Undisclosed

MIT delta v

09 Sep 2017

FAQ About Bloomer Tech

Generating non-invasive digital biomarkers for women's health

Bloomer Tech was founded in 2015.

Bloomer Tech is headquartered in Cambridge, United States.

Bloomer Tech operates in AI, Analytics, Health Care, Health and Wellness, Information Technology, Robotics and Machine Learning. Its work centres on Digital Biomarkers, Cardiovascular Care, Personalized Diagnostics and Textile-Based Sensors.

Bloomer Tech has approximately 8 employees.

Bloomer Tech has completed 5 funding rounds, raising a total of $4.90M. The latest funding stage is Grant.

Top alternatives and competitors to Bloomer Tech include Orikami, Profusa, OptiChroniX, Valencell, Inc., LightHearted AI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Bloomer Tech and Orikami are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Bloomer Tech

General Information

Discover More

About Bloomer Tech

Funding Rounds & Investors (5)

Bloomer Tech Alternatives & Competitors

FAQ About Bloomer Tech